Differentiating Experience Lead

Apply now »
Apply now

Date: Nov 14, 2018

Location: Atlanta, Georgia, US

Harnessing cutting-edge science to deliver world-class experiences to focused patient populations

 

2018 marks the 90th anniversary of UCB. Throughout our 90-year journey, pioneering science, novel innovation and agile entrepreneurship have always been essential components in our company’s DNA.

As a global biopharmaceutical company focusing on neurology and immunology, we have world class expertise in R&D, an exciting world-class pipeline, and extensive access to networks of experts across the globe focused on meeting the unmet needs of patients.

Everything we do starts with a simple question: “How will this create value for people living with severe diseases”?

Across UCB, we are committed to helping focused patient populations reach unique outcomes, supporting patients to achieve their goals, improving individual experiences and enabling people to lead fulfilling lives.

Our unique combination of robust scientific excellence and our heartfelt commitment to improving the lives of patients genuinely sets us apart from our peers. Fundamental to this belief are the amazing people, doing amazing things across our organization. This is especially true for our New Meds, Dev Meds and Marketing Practices teams where colleagues have been working on one of our newest investigational medicines, rozanolixizumab, since its discovery.

Rozanolixizumab (Rozimab) is a novel, first-in-class subcutaneous anti-FcRn antibody therapy for multiple IgG autoantibody-mediated diseases such as Immune thrombocytopaenia (ITP), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Myasthenia Gravis (MG).

In October 2018, we announced positive results from a phase 2 study for Rozimab in patients with MG, achieving proof-of-concept. Based on these results we are now accelerating our development programme.

MG, ITP and CIDP represent new therapy areas for UCB. We will need  to equip ourselves with the right knowledge, the right relationships, the right team members and the right mindset to learn as much as possible from patients, experts and advocacy organizations to ensure we create world-class patient experiences from the outset.

Ensuring our science is tailored to the in-depth insights about the needs of patients, care-givers and healthcare professionals will be critical to our success. Equally important will be to continue building on our extensive evidence base, combining first-class pre-clinical, clinical and real-world data to demonstrate our unique Rozimab value proposition.

We will engage with our stakeholders – patients, researchers, regulators, alliance partners, healthcare professionals, healthcare providers – to ensure we are forward-looking and flexible, and that our approach is tailored to their needs.

To create meaningful value for patients, it is very important to retain our unique patient centric approach and maintain an agility mindset. The scientific candor and energetic delivery which has been so successful over the last 90 Years is as vitally important today as it has always been.

This is no small task. However, the potential for us lead the way in to disrupting and improving the treatment landscape for thousands of people urgently in need of new options, makes this a challenge that is truly worthwhile.

With this in mind, we’re looking to complement our team help us realize our ambition…

Differentiating Experience Lead

rozanolixizumab, for all patient populations

 

Major accountabilities:

 

UCB has just achieved Proof of Concept in an innovative new approach to treating IgG mitigated diseases. The lead of this team will forge an entirely new, positively disruptive presence in the market. The right leader will create a patient experience in targeted rare diseases that will generate a genuine patient preference for UCB’s rozanolixizumab based solutions, inclusive of all touchpoints from branding to access to advocacy to administration… etc.

This role is responsible for Engaging directly with patient communities to generate a distinct credibility for UCB as a leading partner in rare diseases, Building concrete, executable plans to drive patient access, commercial strategies, community/advocacy engagement, integrated device plans, innovative distribution solutions. Deliverables will include:

  • HCP/KOL strategy (brand/science platform)
  • Driving insight generation and definition of targeted populations
  • Building solution propositions and integrated access strategies
  • Strategic external engagement plans
  • Comprehensive experience design – engagement, education, administration, follow-up
  • Leading a team with diverse expertise, and matrixing broadly with other Missions and Practices

The Differentiating Experience Lead will:

  • Directly lead a team of colleagues focused in Commercial, Access, Patient Engagement, Insight generation, Launch planning
  • Work closely with the Development Lead and Platform Strategy Lead to shape the full life-cycle of the asset.
  • Report directly to the Mission Lead, and sit on the Mission Leadership Team
  • Guide collaborative efforts, with multiple Missions, to define and build the Rozimab experience: Lead a cross-functional and matrixed team in building solutions for patients
  • Foster an agile team environment where the right experts flow to the work and patient value-driven priorities lead vs functional norms
  • Design processes for optimal strategic thinking, structure and communication to internal UCB decision bodies
  • Deliver comprehensive solutions on time to empower rapid launch and uptake

 

Your Profile:

Education

  • Educated to a Bachelors level, in a relevant life science or business-related discipline
  • Specific Marketing qualifications or MBA (optional)

 

Experience

  • In-depth knowledge of rare disease industry, including successful global rare launches
  • 10+ years of successful leadership assignments in strategic marketing or other early-stage commercial functions (eg. New Product Planning)
  • Demonstration of successful working relationships with cross-functional stakeholders 

 

Required Skills - General

  • Strategic thinking, project management, problem-solving ability, customer focus, and commitment to quality
  • Excellent interpersonal and leadership skills
  • Marketing excellence with knowledge of key approaches, critical steps
  • Strong project planning skills
  • Excellent communication skills with individuals with different cultural, professional and academic backgrounds, including the ability to simplify complex issues
  • Demonstrated ability to use MS Excel for modeling, financial analysis, and management of tasks, as well as MS PowerPoint

 

Specific Skills / Behaviors

  • Curious and generous
  • Proactive & results driven
  • Entrepreneurial, positive, can-do attitude
  • Scientifically inquisitive
  • Collaborative and balanced with a bias for fast decision making
  • Ability to lead cross-functional meetings and projects across matrix and geographies
  • Excellent command of written and spoken English
  • Strong understanding of principles of good scientific and commercial communication and clear messaging to enable ease of understanding by target audiences
  • Strong understanding of global market access challenges for branded medicines

 

 

UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system.

With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive.  Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.


Job Segment: Neurology, Immunology, Project Manager, Branding, MBA, Healthcare, Technology, Marketing, Management

Apply now »
Apply now
Find similar jobs: